❓ QoN 4209 seeks data on adult mental health outpatient presentations in WA due to illicit stimulant-induced psychosis, broken down by substance type and financial year from 2003-2006. The answer provides the requested data and clarifies categorization and potential for multiple presentations.
AnsweredQoN 4209Legislative Council
QuestionView source ↗
(1) How many adults, diagnosed with illicit stimulant-induced psychosis, have presented themselves or been referred to adult mental health out-patient facilities across Western Australia between - (a) 1 July 2003 - 30 June 2004; (b) 1 July 2004 - 30 June 2005; and (c) 1 July 2005 - 30 June 2006? (2) Of those referred to in (1), how many were due in part or whole as a result of - (a) cannabis; (b) amphetamines, including meth-amphetamine; (c) heroin; (d) cocaine; and (e) other?
(a) 1 July 2003 - 30 June 2004; (b) 1 July 2004 - 30 June 2005; and (c) 1 July 2005 - 30 June 2006? (2) Of those referred to in (1), how many were due in part or whole as a result of - (a) cannabis; (b) amphetamines, including meth-amphetamine; (c) heroin; (d) cocaine; and (e) other?
(b) 1 July 2004 - 30 June 2005; and (c) 1 July 2005 - 30 June 2006?
(c) 1 July 2005 - 30 June 2006?
(b) amphetamines, including meth-amphetamine; (c) heroin; (d) cocaine; and (e) other?
(c) heroin; (d) cocaine; and (e) other?
(d) cocaine; and (e) other?
(e) other?
(b) 1 July 2004 - 30 June 2005 - 561 (c) 1 July 2005 - 30 June 2006 - 565 (2) 1 July 2003 - 30 June 2004 (a) 87 (b) 139 (c) 6 (d) 2 (e) 224 1 July 2004 - 30 June 2005 (a) 107 (b) 171 (c) 9 (d) 5 (e) 298 1 July 2005 - 30 June 2006 (a) 110 (b) 166 (c) 9 (d) 1 (e) 317 Notes: 1. The number of persons in the answers to question 2 exceeds the total in question 1, as a person may attend on another occasion with psychosis caused by a different drug. 2. The "Other" category (e) above includes cases related to alcohol, sedatives and hypnotics, hallucinogens and volatile solvents. It includes "multiple drugs" diagnosis when two or more substances are known to be involved but it is not possible to assess which is contributing most to the condition. It is also used when the exact identity of some or all of the substances is uncertain or unknown. 3. The categories used in responding to question 2 are: 2(a) cannabinoids including cannabis 2(b) stimulants, including amphetamine and methamphetamine 2(c) opioids, including heroin. The specific drugs listed in the question are not able to be individually identified for the first three categories.
(c) 1 July 2005 - 30 June 2006 - 565 (2) 1 July 2003 - 30 June 2004 (a) 87 (b) 139 (c) 6 (d) 2 (e) 224 1 July 2004 - 30 June 2005 (a) 107 (b) 171 (c) 9 (d) 5 (e) 298 1 July 2005 - 30 June 2006 (a) 110 (b) 166 (c) 9 (d) 1 (e) 317 Notes: 1. The number of persons in the answers to question 2 exceeds the total in question 1, as a person may attend on another occasion with psychosis caused by a different drug. 2. The "Other" category (e) above includes cases related to alcohol, sedatives and hypnotics, hallucinogens and volatile solvents. It includes "multiple drugs" diagnosis when two or more substances are known to be involved but it is not possible to assess which is contributing most to the condition. It is also used when the exact identity of some or all of the substances is uncertain or unknown. 3. The categories used in responding to question 2 are: 2(a) cannabinoids including cannabis 2(b) stimulants, including amphetamine and methamphetamine 2(c) opioids, including heroin. The specific drugs listed in the question are not able to be individually identified for the first three categories.
(2) 1 July 2003 - 30 June 2004 (a) 87 (b) 139 (c) 6 (d) 2 (e) 224 1 July 2004 - 30 June 2005 (a) 107 (b) 171 (c) 9 (d) 5 (e) 298 1 July 2005 - 30 June 2006 (a) 110 (b) 166 (c) 9 (d) 1 (e) 317 Notes: 1. The number of persons in the answers to question 2 exceeds the total in question 1, as a person may attend on another occasion with psychosis caused by a different drug. 2. The "Other" category (e) above includes cases related to alcohol, sedatives and hypnotics, hallucinogens and volatile solvents. It includes "multiple drugs" diagnosis when two or more substances are known to be involved but it is not possible to assess which is contributing most to the condition. It is also used when the exact identity of some or all of the substances is uncertain or unknown. 3. The categories used in responding to question 2 are: 2(a) cannabinoids including cannabis 2(b) stimulants, including amphetamine and methamphetamine 2(c) opioids, including heroin. The specific drugs listed in the question are not able to be individually identified for the first three categories.
(a) 87 (b) 139 (c) 6 (d) 2 (e) 224 1 July 2004 - 30 June 2005 (a) 107 (b) 171 (c) 9 (d) 5 (e) 298 1 July 2005 - 30 June 2006 (a) 110 (b) 166 (c) 9 (d) 1 (e) 317 Notes: 1. The number of persons in the answers to question 2 exceeds the total in question 1, as a person may attend on another occasion with psychosis caused by a different drug. 2. The "Other" category (e) above includes cases related to alcohol, sedatives and hypnotics, hallucinogens and volatile solvents. It includes "multiple drugs" diagnosis when two or more substances are known to be involved but it is not possible to assess which is contributing most to the condition. It is also used when the exact identity of some or all of the substances is uncertain or unknown. 3. The categories used in responding to question 2 are: 2(a) cannabinoids including cannabis 2(b) stimulants, including amphetamine and methamphetamine 2(c) opioids, including heroin. The specific drugs listed in the question are not able to be individually identified for the first three categories.
(b) 139 (c) 6 (d) 2 (e) 224 1 July 2004 - 30 June 2005 (a) 107 (b) 171 (c) 9 (d) 5 (e) 298 1 July 2005 - 30 June 2006 (a) 110 (b) 166 (c) 9 (d) 1 (e) 317 Notes: 1. The number of persons in the answers to question 2 exceeds the total in question 1, as a person may attend on another occasion with psychosis caused by a different drug. 2. The "Other" category (e) above includes cases related to alcohol, sedatives and hypnotics, hallucinogens and volatile solvents. It includes "multiple drugs" diagnosis when two or more substances are known to be involved but it is not possible to assess which is contributing most to the condition. It is also used when the exact identity of some or all of the substances is uncertain or unknown. 3. The categories used in responding to question 2 are: 2(a) cannabinoids including cannabis 2(b) stimulants, including amphetamine and methamphetamine 2(c) opioids, including heroin. The specific drugs listed in the question are not able to be individually identified for the first three categories.
(c) 6 (d) 2 (e) 224 1 July 2004 - 30 June 2005 (a) 107 (b) 171 (c) 9 (d) 5 (e) 298 1 July 2005 - 30 June 2006 (a) 110 (b) 166 (c) 9 (d) 1 (e) 317 Notes: 1. The number of persons in the answers to question 2 exceeds the total in question 1, as a person may attend on another occasion with psychosis caused by a different drug. 2. The "Other" category (e) above includes cases related to alcohol, sedatives and hypnotics, hallucinogens and volatile solvents. It includes "multiple drugs" diagnosis when two or more substances are known to be involved but it is not possible to assess which is contributing most to the condition. It is also used when the exact identity of some or all of the substances is uncertain or unknown. 3. The categories used in responding to question 2 are: 2(a) cannabinoids including cannabis 2(b) stimulants, including amphetamine and methamphetamine 2(c) opioids, including heroin. The specific drugs listed in the question are not able to be individually identified for the first three categories.
(d) 2 (e) 224 1 July 2004 - 30 June 2005 (a) 107 (b) 171 (c) 9 (d) 5 (e) 298 1 July 2005 - 30 June 2006 (a) 110 (b) 166 (c) 9 (d) 1 (e) 317 Notes: 1. The number of persons in the answers to question 2 exceeds the total in question 1, as a person may attend on another occasion with psychosis caused by a different drug. 2. The "Other" category (e) above includes cases related to alcohol, sedatives and hypnotics, hallucinogens and volatile solvents. It includes "multiple drugs" diagnosis when two or more substances are known to be involved but it is not possible to assess which is contributing most to the condition. It is also used when the exact identity of some or all of the substances is uncertain or unknown. 3. The categories used in responding to question 2 are: 2(a) cannabinoids including cannabis 2(b) stimulants, including amphetamine and methamphetamine 2(c) opioids, including heroin. The specific drugs listed in the question are not able to be individually identified for the first three categories.
(e) 224 1 July 2004 - 30 June 2005 (a) 107 (b) 171 (c) 9 (d) 5 (e) 298 1 July 2005 - 30 June 2006 (a) 110 (b) 166 (c) 9 (d) 1 (e) 317 Notes: 1. The number of persons in the answers to question 2 exceeds the total in question 1, as a person may attend on another occasion with psychosis caused by a different drug. 2. The "Other" category (e) above includes cases related to alcohol, sedatives and hypnotics, hallucinogens and volatile solvents. It includes "multiple drugs" diagnosis when two or more substances are known to be involved but it is not possible to assess which is contributing most to the condition. It is also used when the exact identity of some or all of the substances is uncertain or unknown. 3. The categories used in responding to question 2 are: 2(a) cannabinoids including cannabis 2(b) stimulants, including amphetamine and methamphetamine 2(c) opioids, including heroin. The specific drugs listed in the question are not able to be individually identified for the first three categories.
1 July 2004 - 30 June 2005 (a) 107 (b) 171 (c) 9 (d) 5 (e) 298 1 July 2005 - 30 June 2006 (a) 110 (b) 166 (c) 9 (d) 1 (e) 317 Notes: 1. The number of persons in the answers to question 2 exceeds the total in question 1, as a person may attend on another occasion with psychosis caused by a different drug. 2. The "Other" category (e) above includes cases related to alcohol, sedatives and hypnotics, hallucinogens and volatile solvents. It includes "multiple drugs" diagnosis when two or more substances are known to be involved but it is not possible to assess which is contributing most to the condition. It is also used when the exact identity of some or all of the substances is uncertain or unknown. 3. The categories used in responding to question 2 are: 2(a) cannabinoids including cannabis 2(b) stimulants, including amphetamine and methamphetamine 2(c) opioids, including heroin. The specific drugs listed in the question are not able to be individually identified for the first three categories.
(a) 107 (b) 171 (c) 9 (d) 5 (e) 298 1 July 2005 - 30 June 2006 (a) 110 (b) 166 (c) 9 (d) 1 (e) 317 Notes: 1. The number of persons in the answers to question 2 exceeds the total in question 1, as a person may attend on another occasion with psychosis caused by a different drug. 2. The "Other" category (e) above includes cases related to alcohol, sedatives and hypnotics, hallucinogens and volatile solvents. It includes "multiple drugs" diagnosis when two or more substances are known to be involved but it is not possible to assess which is contributing most to the condition. It is also used when the exact identity of some or all of the substances is uncertain or unknown. 3. The categories used in responding to question 2 are: 2(a) cannabinoids including cannabis 2(b) stimulants, including amphetamine and methamphetamine 2(c) opioids, including heroin. The specific drugs listed in the question are not able to be individually identified for the first three categories.
(b) 171 (c) 9 (d) 5 (e) 298 1 July 2005 - 30 June 2006 (a) 110 (b) 166 (c) 9 (d) 1 (e) 317 Notes: 1. The number of persons in the answers to question 2 exceeds the total in question 1, as a person may attend on another occasion with psychosis caused by a different drug. 2. The "Other" category (e) above includes cases related to alcohol, sedatives and hypnotics, hallucinogens and volatile solvents. It includes "multiple drugs" diagnosis when two or more substances are known to be involved but it is not possible to assess which is contributing most to the condition. It is also used when the exact identity of some or all of the substances is uncertain or unknown. 3. The categories used in responding to question 2 are: 2(a) cannabinoids including cannabis 2(b) stimulants, including amphetamine and methamphetamine 2(c) opioids, including heroin. The specific drugs listed in the question are not able to be individually identified for the first three categories.
(c) 9 (d) 5 (e) 298 1 July 2005 - 30 June 2006 (a) 110 (b) 166 (c) 9 (d) 1 (e) 317 Notes: 1. The number of persons in the answers to question 2 exceeds the total in question 1, as a person may attend on another occasion with psychosis caused by a different drug. 2. The "Other" category (e) above includes cases related to alcohol, sedatives and hypnotics, hallucinogens and volatile solvents. It includes "multiple drugs" diagnosis when two or more substances are known to be involved but it is not possible to assess which is contributing most to the condition. It is also used when the exact identity of some or all of the substances is uncertain or unknown. 3. The categories used in responding to question 2 are: 2(a) cannabinoids including cannabis 2(b) stimulants, including amphetamine and methamphetamine 2(c) opioids, including heroin. The specific drugs listed in the question are not able to be individually identified for the first three categories.
(d) 5 (e) 298 1 July 2005 - 30 June 2006 (a) 110 (b) 166 (c) 9 (d) 1 (e) 317 Notes: 1. The number of persons in the answers to question 2 exceeds the total in question 1, as a person may attend on another occasion with psychosis caused by a different drug. 2. The "Other" category (e) above includes cases related to alcohol, sedatives and hypnotics, hallucinogens and volatile solvents. It includes "multiple drugs" diagnosis when two or more substances are known to be involved but it is not possible to assess which is contributing most to the condition. It is also used when the exact identity of some or all of the substances is uncertain or unknown. 3. The categories used in responding to question 2 are: 2(a) cannabinoids including cannabis 2(b) stimulants, including amphetamine and methamphetamine 2(c) opioids, including heroin. The specific drugs listed in the question are not able to be individually identified for the first three categories.
(e) 298 1 July 2005 - 30 June 2006 (a) 110 (b) 166 (c) 9 (d) 1 (e) 317 Notes: 1. The number of persons in the answers to question 2 exceeds the total in question 1, as a person may attend on another occasion with psychosis caused by a different drug. 2. The "Other" category (e) above includes cases related to alcohol, sedatives and hypnotics, hallucinogens and volatile solvents. It includes "multiple drugs" diagnosis when two or more substances are known to be involved but it is not possible to assess which is contributing most to the condition. It is also used when the exact identity of some or all of the substances is uncertain or unknown. 3. The categories used in responding to question 2 are: 2(a) cannabinoids including cannabis 2(b) stimulants, including amphetamine and methamphetamine 2(c) opioids, including heroin. The specific drugs listed in the question are not able to be individually identified for the first three categories.
1 July 2005 - 30 June 2006 (a) 110 (b) 166 (c) 9 (d) 1 (e) 317 Notes: 1. The number of persons in the answers to question 2 exceeds the total in question 1, as a person may attend on another occasion with psychosis caused by a different drug. 2. The "Other" category (e) above includes cases related to alcohol, sedatives and hypnotics, hallucinogens and volatile solvents. It includes "multiple drugs" diagnosis when two or more substances are known to be involved but it is not possible to assess which is contributing most to the condition. It is also used when the exact identity of some or all of the substances is uncertain or unknown. 3. The categories used in responding to question 2 are: 2(a) cannabinoids including cannabis 2(b) stimulants, including amphetamine and methamphetamine 2(c) opioids, including heroin. The specific drugs listed in the question are not able to be individually identified for the first three categories.
(a) 110 (b) 166 (c) 9 (d) 1 (e) 317 Notes: 1. The number of persons in the answers to question 2 exceeds the total in question 1, as a person may attend on another occasion with psychosis caused by a different drug. 2. The "Other" category (e) above includes cases related to alcohol, sedatives and hypnotics, hallucinogens and volatile solvents. It includes "multiple drugs" diagnosis when two or more substances are known to be involved but it is not possible to assess which is contributing most to the condition. It is also used when the exact identity of some or all of the substances is uncertain or unknown. 3. The categories used in responding to question 2 are: 2(a) cannabinoids including cannabis 2(b) stimulants, including amphetamine and methamphetamine 2(c) opioids, including heroin. The specific drugs listed in the question are not able to be individually identified for the first three categories.
(b) 166 (c) 9 (d) 1 (e) 317 Notes: 1. The number of persons in the answers to question 2 exceeds the total in question 1, as a person may attend on another occasion with psychosis caused by a different drug. 2. The "Other" category (e) above includes cases related to alcohol, sedatives and hypnotics, hallucinogens and volatile solvents. It includes "multiple drugs" diagnosis when two or more substances are known to be involved but it is not possible to assess which is contributing most to the condition. It is also used when the exact identity of some or all of the substances is uncertain or unknown. 3. The categories used in responding to question 2 are: 2(a) cannabinoids including cannabis 2(b) stimulants, including amphetamine and methamphetamine 2(c) opioids, including heroin. The specific drugs listed in the question are not able to be individually identified for the first three categories.
(c) 9 (d) 1 (e) 317 Notes: 1. The number of persons in the answers to question 2 exceeds the total in question 1, as a person may attend on another occasion with psychosis caused by a different drug. 2. The "Other" category (e) above includes cases related to alcohol, sedatives and hypnotics, hallucinogens and volatile solvents. It includes "multiple drugs" diagnosis when two or more substances are known to be involved but it is not possible to assess which is contributing most to the condition. It is also used when the exact identity of some or all of the substances is uncertain or unknown. 3. The categories used in responding to question 2 are: 2(a) cannabinoids including cannabis 2(b) stimulants, including amphetamine and methamphetamine 2(c) opioids, including heroin. The specific drugs listed in the question are not able to be individually identified for the first three categories.
(d) 1 (e) 317 Notes: 1. The number of persons in the answers to question 2 exceeds the total in question 1, as a person may attend on another occasion with psychosis caused by a different drug. 2. The "Other" category (e) above includes cases related to alcohol, sedatives and hypnotics, hallucinogens and volatile solvents. It includes "multiple drugs" diagnosis when two or more substances are known to be involved but it is not possible to assess which is contributing most to the condition. It is also used when the exact identity of some or all of the substances is uncertain or unknown. 3. The categories used in responding to question 2 are: 2(a) cannabinoids including cannabis 2(b) stimulants, including amphetamine and methamphetamine 2(c) opioids, including heroin. The specific drugs listed in the question are not able to be individually identified for the first three categories.
(e) 317 Notes: 1. The number of persons in the answers to question 2 exceeds the total in question 1, as a person may attend on another occasion with psychosis caused by a different drug. 2. The "Other" category (e) above includes cases related to alcohol, sedatives and hypnotics, hallucinogens and volatile solvents. It includes "multiple drugs" diagnosis when two or more substances are known to be involved but it is not possible to assess which is contributing most to the condition. It is also used when the exact identity of some or all of the substances is uncertain or unknown. 3. The categories used in responding to question 2 are: 2(a) cannabinoids including cannabis 2(b) stimulants, including amphetamine and methamphetamine 2(c) opioids, including heroin. The specific drugs listed in the question are not able to be individually identified for the first three categories.
Notes: 1. The number of persons in the answers to question 2 exceeds the total in question 1, as a person may attend on another occasion with psychosis caused by a different drug. 2. The "Other" category (e) above includes cases related to alcohol, sedatives and hypnotics, hallucinogens and volatile solvents. It includes "multiple drugs" diagnosis when two or more substances are known to be involved but it is not possible to assess which is contributing most to the condition. It is also used when the exact identity of some or all of the substances is uncertain or unknown. 3. The categories used in responding to question 2 are: 2(a) cannabinoids including cannabis 2(b) stimulants, including amphetamine and methamphetamine 2(c) opioids, including heroin. The specific drugs listed in the question are not able to be individually identified for the first three categories.
1. The number of persons in the answers to question 2 exceeds the total in question 1, as a person may attend on another occasion with psychosis caused by a different drug. 2. The "Other" category (e) above includes cases related to alcohol, sedatives and hypnotics, hallucinogens and volatile solvents. It includes "multiple drugs" diagnosis when two or more substances are known to be involved but it is not possible to assess which is contributing most to the condition. It is also used when the exact identity of some or all of the substances is uncertain or unknown. 3. The categories used in responding to question 2 are: 2(a) cannabinoids including cannabis 2(b) stimulants, including amphetamine and methamphetamine 2(c) opioids, including heroin. The specific drugs listed in the question are not able to be individually identified for the first three categories.
2. The "Other" category (e) above includes cases related to alcohol, sedatives and hypnotics, hallucinogens and volatile solvents. It includes "multiple drugs" diagnosis when two or more substances are known to be involved but it is not possible to assess which is contributing most to the condition. It is also used when the exact identity of some or all of the substances is uncertain or unknown. 3. The categories used in responding to question 2 are: 2(a) cannabinoids including cannabis 2(b) stimulants, including amphetamine and methamphetamine 2(c) opioids, including heroin. The specific drugs listed in the question are not able to be individually identified for the first three categories.
3. The categories used in responding to question 2 are: 2(a) cannabinoids including cannabis 2(b) stimulants, including amphetamine and methamphetamine 2(c) opioids, including heroin. The specific drugs listed in the question are not able to be individually identified for the first three categories.
2(a) cannabinoids including cannabis 2(b) stimulants, including amphetamine and methamphetamine 2(c) opioids, including heroin. The specific drugs listed in the question are not able to be individually identified for the first three categories.
2(b) stimulants, including amphetamine and methamphetamine 2(c) opioids, including heroin. The specific drugs listed in the question are not able to be individually identified for the first three categories.
2(c) opioids, including heroin. The specific drugs listed in the question are not able to be individually identified for the first three categories.
The specific drugs listed in the question are not able to be individually identified for the first three categories.
(a) 1 July 2003 - 30 June 2004; (b) 1 July 2004 - 30 June 2005; and (c) 1 July 2005 - 30 June 2006? (2) Of those referred to in (1), how many were due in part or whole as a result of - (a) cannabis; (b) amphetamines, including meth-amphetamine; (c) heroin; (d) cocaine; and (e) other?
(b) 1 July 2004 - 30 June 2005; and (c) 1 July 2005 - 30 June 2006?
(c) 1 July 2005 - 30 June 2006?
(b) amphetamines, including meth-amphetamine; (c) heroin; (d) cocaine; and (e) other?
(c) heroin; (d) cocaine; and (e) other?
(d) cocaine; and (e) other?
(e) other?
(b) 1 July 2004 - 30 June 2005 - 561 (c) 1 July 2005 - 30 June 2006 - 565 (2) 1 July 2003 - 30 June 2004 (a) 87 (b) 139 (c) 6 (d) 2 (e) 224 1 July 2004 - 30 June 2005 (a) 107 (b) 171 (c) 9 (d) 5 (e) 298 1 July 2005 - 30 June 2006 (a) 110 (b) 166 (c) 9 (d) 1 (e) 317 Notes: 1. The number of persons in the answers to question 2 exceeds the total in question 1, as a person may attend on another occasion with psychosis caused by a different drug. 2. The "Other" category (e) above includes cases related to alcohol, sedatives and hypnotics, hallucinogens and volatile solvents. It includes "multiple drugs" diagnosis when two or more substances are known to be involved but it is not possible to assess which is contributing most to the condition. It is also used when the exact identity of some or all of the substances is uncertain or unknown. 3. The categories used in responding to question 2 are: 2(a) cannabinoids including cannabis 2(b) stimulants, including amphetamine and methamphetamine 2(c) opioids, including heroin. The specific drugs listed in the question are not able to be individually identified for the first three categories.
(c) 1 July 2005 - 30 June 2006 - 565 (2) 1 July 2003 - 30 June 2004 (a) 87 (b) 139 (c) 6 (d) 2 (e) 224 1 July 2004 - 30 June 2005 (a) 107 (b) 171 (c) 9 (d) 5 (e) 298 1 July 2005 - 30 June 2006 (a) 110 (b) 166 (c) 9 (d) 1 (e) 317 Notes: 1. The number of persons in the answers to question 2 exceeds the total in question 1, as a person may attend on another occasion with psychosis caused by a different drug. 2. The "Other" category (e) above includes cases related to alcohol, sedatives and hypnotics, hallucinogens and volatile solvents. It includes "multiple drugs" diagnosis when two or more substances are known to be involved but it is not possible to assess which is contributing most to the condition. It is also used when the exact identity of some or all of the substances is uncertain or unknown. 3. The categories used in responding to question 2 are: 2(a) cannabinoids including cannabis 2(b) stimulants, including amphetamine and methamphetamine 2(c) opioids, including heroin. The specific drugs listed in the question are not able to be individually identified for the first three categories.
(2) 1 July 2003 - 30 June 2004 (a) 87 (b) 139 (c) 6 (d) 2 (e) 224 1 July 2004 - 30 June 2005 (a) 107 (b) 171 (c) 9 (d) 5 (e) 298 1 July 2005 - 30 June 2006 (a) 110 (b) 166 (c) 9 (d) 1 (e) 317 Notes: 1. The number of persons in the answers to question 2 exceeds the total in question 1, as a person may attend on another occasion with psychosis caused by a different drug. 2. The "Other" category (e) above includes cases related to alcohol, sedatives and hypnotics, hallucinogens and volatile solvents. It includes "multiple drugs" diagnosis when two or more substances are known to be involved but it is not possible to assess which is contributing most to the condition. It is also used when the exact identity of some or all of the substances is uncertain or unknown. 3. The categories used in responding to question 2 are: 2(a) cannabinoids including cannabis 2(b) stimulants, including amphetamine and methamphetamine 2(c) opioids, including heroin. The specific drugs listed in the question are not able to be individually identified for the first three categories.
(a) 87 (b) 139 (c) 6 (d) 2 (e) 224 1 July 2004 - 30 June 2005 (a) 107 (b) 171 (c) 9 (d) 5 (e) 298 1 July 2005 - 30 June 2006 (a) 110 (b) 166 (c) 9 (d) 1 (e) 317 Notes: 1. The number of persons in the answers to question 2 exceeds the total in question 1, as a person may attend on another occasion with psychosis caused by a different drug. 2. The "Other" category (e) above includes cases related to alcohol, sedatives and hypnotics, hallucinogens and volatile solvents. It includes "multiple drugs" diagnosis when two or more substances are known to be involved but it is not possible to assess which is contributing most to the condition. It is also used when the exact identity of some or all of the substances is uncertain or unknown. 3. The categories used in responding to question 2 are: 2(a) cannabinoids including cannabis 2(b) stimulants, including amphetamine and methamphetamine 2(c) opioids, including heroin. The specific drugs listed in the question are not able to be individually identified for the first three categories.
(b) 139 (c) 6 (d) 2 (e) 224 1 July 2004 - 30 June 2005 (a) 107 (b) 171 (c) 9 (d) 5 (e) 298 1 July 2005 - 30 June 2006 (a) 110 (b) 166 (c) 9 (d) 1 (e) 317 Notes: 1. The number of persons in the answers to question 2 exceeds the total in question 1, as a person may attend on another occasion with psychosis caused by a different drug. 2. The "Other" category (e) above includes cases related to alcohol, sedatives and hypnotics, hallucinogens and volatile solvents. It includes "multiple drugs" diagnosis when two or more substances are known to be involved but it is not possible to assess which is contributing most to the condition. It is also used when the exact identity of some or all of the substances is uncertain or unknown. 3. The categories used in responding to question 2 are: 2(a) cannabinoids including cannabis 2(b) stimulants, including amphetamine and methamphetamine 2(c) opioids, including heroin. The specific drugs listed in the question are not able to be individually identified for the first three categories.
(c) 6 (d) 2 (e) 224 1 July 2004 - 30 June 2005 (a) 107 (b) 171 (c) 9 (d) 5 (e) 298 1 July 2005 - 30 June 2006 (a) 110 (b) 166 (c) 9 (d) 1 (e) 317 Notes: 1. The number of persons in the answers to question 2 exceeds the total in question 1, as a person may attend on another occasion with psychosis caused by a different drug. 2. The "Other" category (e) above includes cases related to alcohol, sedatives and hypnotics, hallucinogens and volatile solvents. It includes "multiple drugs" diagnosis when two or more substances are known to be involved but it is not possible to assess which is contributing most to the condition. It is also used when the exact identity of some or all of the substances is uncertain or unknown. 3. The categories used in responding to question 2 are: 2(a) cannabinoids including cannabis 2(b) stimulants, including amphetamine and methamphetamine 2(c) opioids, including heroin. The specific drugs listed in the question are not able to be individually identified for the first three categories.
(d) 2 (e) 224 1 July 2004 - 30 June 2005 (a) 107 (b) 171 (c) 9 (d) 5 (e) 298 1 July 2005 - 30 June 2006 (a) 110 (b) 166 (c) 9 (d) 1 (e) 317 Notes: 1. The number of persons in the answers to question 2 exceeds the total in question 1, as a person may attend on another occasion with psychosis caused by a different drug. 2. The "Other" category (e) above includes cases related to alcohol, sedatives and hypnotics, hallucinogens and volatile solvents. It includes "multiple drugs" diagnosis when two or more substances are known to be involved but it is not possible to assess which is contributing most to the condition. It is also used when the exact identity of some or all of the substances is uncertain or unknown. 3. The categories used in responding to question 2 are: 2(a) cannabinoids including cannabis 2(b) stimulants, including amphetamine and methamphetamine 2(c) opioids, including heroin. The specific drugs listed in the question are not able to be individually identified for the first three categories.
(e) 224 1 July 2004 - 30 June 2005 (a) 107 (b) 171 (c) 9 (d) 5 (e) 298 1 July 2005 - 30 June 2006 (a) 110 (b) 166 (c) 9 (d) 1 (e) 317 Notes: 1. The number of persons in the answers to question 2 exceeds the total in question 1, as a person may attend on another occasion with psychosis caused by a different drug. 2. The "Other" category (e) above includes cases related to alcohol, sedatives and hypnotics, hallucinogens and volatile solvents. It includes "multiple drugs" diagnosis when two or more substances are known to be involved but it is not possible to assess which is contributing most to the condition. It is also used when the exact identity of some or all of the substances is uncertain or unknown. 3. The categories used in responding to question 2 are: 2(a) cannabinoids including cannabis 2(b) stimulants, including amphetamine and methamphetamine 2(c) opioids, including heroin. The specific drugs listed in the question are not able to be individually identified for the first three categories.
1 July 2004 - 30 June 2005 (a) 107 (b) 171 (c) 9 (d) 5 (e) 298 1 July 2005 - 30 June 2006 (a) 110 (b) 166 (c) 9 (d) 1 (e) 317 Notes: 1. The number of persons in the answers to question 2 exceeds the total in question 1, as a person may attend on another occasion with psychosis caused by a different drug. 2. The "Other" category (e) above includes cases related to alcohol, sedatives and hypnotics, hallucinogens and volatile solvents. It includes "multiple drugs" diagnosis when two or more substances are known to be involved but it is not possible to assess which is contributing most to the condition. It is also used when the exact identity of some or all of the substances is uncertain or unknown. 3. The categories used in responding to question 2 are: 2(a) cannabinoids including cannabis 2(b) stimulants, including amphetamine and methamphetamine 2(c) opioids, including heroin. The specific drugs listed in the question are not able to be individually identified for the first three categories.
(a) 107 (b) 171 (c) 9 (d) 5 (e) 298 1 July 2005 - 30 June 2006 (a) 110 (b) 166 (c) 9 (d) 1 (e) 317 Notes: 1. The number of persons in the answers to question 2 exceeds the total in question 1, as a person may attend on another occasion with psychosis caused by a different drug. 2. The "Other" category (e) above includes cases related to alcohol, sedatives and hypnotics, hallucinogens and volatile solvents. It includes "multiple drugs" diagnosis when two or more substances are known to be involved but it is not possible to assess which is contributing most to the condition. It is also used when the exact identity of some or all of the substances is uncertain or unknown. 3. The categories used in responding to question 2 are: 2(a) cannabinoids including cannabis 2(b) stimulants, including amphetamine and methamphetamine 2(c) opioids, including heroin. The specific drugs listed in the question are not able to be individually identified for the first three categories.
(b) 171 (c) 9 (d) 5 (e) 298 1 July 2005 - 30 June 2006 (a) 110 (b) 166 (c) 9 (d) 1 (e) 317 Notes: 1. The number of persons in the answers to question 2 exceeds the total in question 1, as a person may attend on another occasion with psychosis caused by a different drug. 2. The "Other" category (e) above includes cases related to alcohol, sedatives and hypnotics, hallucinogens and volatile solvents. It includes "multiple drugs" diagnosis when two or more substances are known to be involved but it is not possible to assess which is contributing most to the condition. It is also used when the exact identity of some or all of the substances is uncertain or unknown. 3. The categories used in responding to question 2 are: 2(a) cannabinoids including cannabis 2(b) stimulants, including amphetamine and methamphetamine 2(c) opioids, including heroin. The specific drugs listed in the question are not able to be individually identified for the first three categories.
(c) 9 (d) 5 (e) 298 1 July 2005 - 30 June 2006 (a) 110 (b) 166 (c) 9 (d) 1 (e) 317 Notes: 1. The number of persons in the answers to question 2 exceeds the total in question 1, as a person may attend on another occasion with psychosis caused by a different drug. 2. The "Other" category (e) above includes cases related to alcohol, sedatives and hypnotics, hallucinogens and volatile solvents. It includes "multiple drugs" diagnosis when two or more substances are known to be involved but it is not possible to assess which is contributing most to the condition. It is also used when the exact identity of some or all of the substances is uncertain or unknown. 3. The categories used in responding to question 2 are: 2(a) cannabinoids including cannabis 2(b) stimulants, including amphetamine and methamphetamine 2(c) opioids, including heroin. The specific drugs listed in the question are not able to be individually identified for the first three categories.
(d) 5 (e) 298 1 July 2005 - 30 June 2006 (a) 110 (b) 166 (c) 9 (d) 1 (e) 317 Notes: 1. The number of persons in the answers to question 2 exceeds the total in question 1, as a person may attend on another occasion with psychosis caused by a different drug. 2. The "Other" category (e) above includes cases related to alcohol, sedatives and hypnotics, hallucinogens and volatile solvents. It includes "multiple drugs" diagnosis when two or more substances are known to be involved but it is not possible to assess which is contributing most to the condition. It is also used when the exact identity of some or all of the substances is uncertain or unknown. 3. The categories used in responding to question 2 are: 2(a) cannabinoids including cannabis 2(b) stimulants, including amphetamine and methamphetamine 2(c) opioids, including heroin. The specific drugs listed in the question are not able to be individually identified for the first three categories.
(e) 298 1 July 2005 - 30 June 2006 (a) 110 (b) 166 (c) 9 (d) 1 (e) 317 Notes: 1. The number of persons in the answers to question 2 exceeds the total in question 1, as a person may attend on another occasion with psychosis caused by a different drug. 2. The "Other" category (e) above includes cases related to alcohol, sedatives and hypnotics, hallucinogens and volatile solvents. It includes "multiple drugs" diagnosis when two or more substances are known to be involved but it is not possible to assess which is contributing most to the condition. It is also used when the exact identity of some or all of the substances is uncertain or unknown. 3. The categories used in responding to question 2 are: 2(a) cannabinoids including cannabis 2(b) stimulants, including amphetamine and methamphetamine 2(c) opioids, including heroin. The specific drugs listed in the question are not able to be individually identified for the first three categories.
1 July 2005 - 30 June 2006 (a) 110 (b) 166 (c) 9 (d) 1 (e) 317 Notes: 1. The number of persons in the answers to question 2 exceeds the total in question 1, as a person may attend on another occasion with psychosis caused by a different drug. 2. The "Other" category (e) above includes cases related to alcohol, sedatives and hypnotics, hallucinogens and volatile solvents. It includes "multiple drugs" diagnosis when two or more substances are known to be involved but it is not possible to assess which is contributing most to the condition. It is also used when the exact identity of some or all of the substances is uncertain or unknown. 3. The categories used in responding to question 2 are: 2(a) cannabinoids including cannabis 2(b) stimulants, including amphetamine and methamphetamine 2(c) opioids, including heroin. The specific drugs listed in the question are not able to be individually identified for the first three categories.
(a) 110 (b) 166 (c) 9 (d) 1 (e) 317 Notes: 1. The number of persons in the answers to question 2 exceeds the total in question 1, as a person may attend on another occasion with psychosis caused by a different drug. 2. The "Other" category (e) above includes cases related to alcohol, sedatives and hypnotics, hallucinogens and volatile solvents. It includes "multiple drugs" diagnosis when two or more substances are known to be involved but it is not possible to assess which is contributing most to the condition. It is also used when the exact identity of some or all of the substances is uncertain or unknown. 3. The categories used in responding to question 2 are: 2(a) cannabinoids including cannabis 2(b) stimulants, including amphetamine and methamphetamine 2(c) opioids, including heroin. The specific drugs listed in the question are not able to be individually identified for the first three categories.
(b) 166 (c) 9 (d) 1 (e) 317 Notes: 1. The number of persons in the answers to question 2 exceeds the total in question 1, as a person may attend on another occasion with psychosis caused by a different drug. 2. The "Other" category (e) above includes cases related to alcohol, sedatives and hypnotics, hallucinogens and volatile solvents. It includes "multiple drugs" diagnosis when two or more substances are known to be involved but it is not possible to assess which is contributing most to the condition. It is also used when the exact identity of some or all of the substances is uncertain or unknown. 3. The categories used in responding to question 2 are: 2(a) cannabinoids including cannabis 2(b) stimulants, including amphetamine and methamphetamine 2(c) opioids, including heroin. The specific drugs listed in the question are not able to be individually identified for the first three categories.
(c) 9 (d) 1 (e) 317 Notes: 1. The number of persons in the answers to question 2 exceeds the total in question 1, as a person may attend on another occasion with psychosis caused by a different drug. 2. The "Other" category (e) above includes cases related to alcohol, sedatives and hypnotics, hallucinogens and volatile solvents. It includes "multiple drugs" diagnosis when two or more substances are known to be involved but it is not possible to assess which is contributing most to the condition. It is also used when the exact identity of some or all of the substances is uncertain or unknown. 3. The categories used in responding to question 2 are: 2(a) cannabinoids including cannabis 2(b) stimulants, including amphetamine and methamphetamine 2(c) opioids, including heroin. The specific drugs listed in the question are not able to be individually identified for the first three categories.
(d) 1 (e) 317 Notes: 1. The number of persons in the answers to question 2 exceeds the total in question 1, as a person may attend on another occasion with psychosis caused by a different drug. 2. The "Other" category (e) above includes cases related to alcohol, sedatives and hypnotics, hallucinogens and volatile solvents. It includes "multiple drugs" diagnosis when two or more substances are known to be involved but it is not possible to assess which is contributing most to the condition. It is also used when the exact identity of some or all of the substances is uncertain or unknown. 3. The categories used in responding to question 2 are: 2(a) cannabinoids including cannabis 2(b) stimulants, including amphetamine and methamphetamine 2(c) opioids, including heroin. The specific drugs listed in the question are not able to be individually identified for the first three categories.
(e) 317 Notes: 1. The number of persons in the answers to question 2 exceeds the total in question 1, as a person may attend on another occasion with psychosis caused by a different drug. 2. The "Other" category (e) above includes cases related to alcohol, sedatives and hypnotics, hallucinogens and volatile solvents. It includes "multiple drugs" diagnosis when two or more substances are known to be involved but it is not possible to assess which is contributing most to the condition. It is also used when the exact identity of some or all of the substances is uncertain or unknown. 3. The categories used in responding to question 2 are: 2(a) cannabinoids including cannabis 2(b) stimulants, including amphetamine and methamphetamine 2(c) opioids, including heroin. The specific drugs listed in the question are not able to be individually identified for the first three categories.
Notes: 1. The number of persons in the answers to question 2 exceeds the total in question 1, as a person may attend on another occasion with psychosis caused by a different drug. 2. The "Other" category (e) above includes cases related to alcohol, sedatives and hypnotics, hallucinogens and volatile solvents. It includes "multiple drugs" diagnosis when two or more substances are known to be involved but it is not possible to assess which is contributing most to the condition. It is also used when the exact identity of some or all of the substances is uncertain or unknown. 3. The categories used in responding to question 2 are: 2(a) cannabinoids including cannabis 2(b) stimulants, including amphetamine and methamphetamine 2(c) opioids, including heroin. The specific drugs listed in the question are not able to be individually identified for the first three categories.
1. The number of persons in the answers to question 2 exceeds the total in question 1, as a person may attend on another occasion with psychosis caused by a different drug. 2. The "Other" category (e) above includes cases related to alcohol, sedatives and hypnotics, hallucinogens and volatile solvents. It includes "multiple drugs" diagnosis when two or more substances are known to be involved but it is not possible to assess which is contributing most to the condition. It is also used when the exact identity of some or all of the substances is uncertain or unknown. 3. The categories used in responding to question 2 are: 2(a) cannabinoids including cannabis 2(b) stimulants, including amphetamine and methamphetamine 2(c) opioids, including heroin. The specific drugs listed in the question are not able to be individually identified for the first three categories.
2. The "Other" category (e) above includes cases related to alcohol, sedatives and hypnotics, hallucinogens and volatile solvents. It includes "multiple drugs" diagnosis when two or more substances are known to be involved but it is not possible to assess which is contributing most to the condition. It is also used when the exact identity of some or all of the substances is uncertain or unknown. 3. The categories used in responding to question 2 are: 2(a) cannabinoids including cannabis 2(b) stimulants, including amphetamine and methamphetamine 2(c) opioids, including heroin. The specific drugs listed in the question are not able to be individually identified for the first three categories.
3. The categories used in responding to question 2 are: 2(a) cannabinoids including cannabis 2(b) stimulants, including amphetamine and methamphetamine 2(c) opioids, including heroin. The specific drugs listed in the question are not able to be individually identified for the first three categories.
2(a) cannabinoids including cannabis 2(b) stimulants, including amphetamine and methamphetamine 2(c) opioids, including heroin. The specific drugs listed in the question are not able to be individually identified for the first three categories.
2(b) stimulants, including amphetamine and methamphetamine 2(c) opioids, including heroin. The specific drugs listed in the question are not able to be individually identified for the first three categories.
2(c) opioids, including heroin. The specific drugs listed in the question are not able to be individually identified for the first three categories.
The specific drugs listed in the question are not able to be individually identified for the first three categories.
AnswerView source ↗
Answered
14 November 2006
Responded by
Parliamentary Secretary representing the Minister for Health
Response time
21 days
(1) (a) 1 July 2003 - 30 June 2004 - 445
(b) 1 July 2004 - 30 June 2005 - 561
(c) 1 July 2005 - 30 June 2006 - 565
(2) 1 July 2003 - 30 June 2004
(a) 87
(b) 139
(c) 6
(d) 2
(e) 224
1 July 2004 - 30 June 2005
(a) 107
(b) 171
(c) 9
(d) 5
(e) 298
1 July 2005 - 30 June 2006
(a) 110
(b) 166
(c) 9
(d) 1
(e) 317
Notes:
1. The number of persons in the answers to question 2 exceeds the total in question 1, as a person may attend on another occasion with psychosis caused by a different drug.
2. The "Other" category (e) above includes cases related to alcohol, sedatives and hypnotics, hallucinogens and volatile solvents. It includes "multiple drugs" diagnosis when two or more substances are known to be involved but it is not possible to assess which is contributing most to the condition. It is also used when the exact identity of some or all of the substances is uncertain or unknown.
3. The categories used in responding to question 2 are:
2(a) cannabinoids including cannabis
2(b) stimulants, including amphetamine and methamphetamine
2(c) opioids, including heroin.
The specific drugs listed in the question are not able to be individually identified for the first three categories.
(b) 1 July 2004 - 30 June 2005 - 561
(c) 1 July 2005 - 30 June 2006 - 565
(2) 1 July 2003 - 30 June 2004
(a) 87
(b) 139
(c) 6
(d) 2
(e) 224
1 July 2004 - 30 June 2005
(a) 107
(b) 171
(c) 9
(d) 5
(e) 298
1 July 2005 - 30 June 2006
(a) 110
(b) 166
(c) 9
(d) 1
(e) 317
Notes:
1. The number of persons in the answers to question 2 exceeds the total in question 1, as a person may attend on another occasion with psychosis caused by a different drug.
2. The "Other" category (e) above includes cases related to alcohol, sedatives and hypnotics, hallucinogens and volatile solvents. It includes "multiple drugs" diagnosis when two or more substances are known to be involved but it is not possible to assess which is contributing most to the condition. It is also used when the exact identity of some or all of the substances is uncertain or unknown.
3. The categories used in responding to question 2 are:
2(a) cannabinoids including cannabis
2(b) stimulants, including amphetamine and methamphetamine
2(c) opioids, including heroin.
The specific drugs listed in the question are not able to be individually identified for the first three categories.
Explore WA Government Data
Search the full archive in the free dashboard, or query programmatically via API.
Explore more
Government Gazette
Appointments, regulatory notices, planning changes.
Hansard
Debates, questions, speeches and sentiment.
Tabled Papers
Reports and documents tabled in Parliament.
Committees
Committee profiles and recent reports.
Regulations
Subsidiary legislation with filters and summaries.
Bills
Proposed laws and parliamentary progress.
Acts
Current WA legislation and summaries.
Explanatory Memoranda
Bills with EMs (text/PDF) available.
Members
MP profiles, party breakdown and rankings.
Pollie Rankings
Data-driven rankings across 19 categories.
Amendment Chains
Track how schemes and regulations evolve over time.